Point of Care & Rapid Diagnosticsの世界市場規模調査、製品別(COVID-19検査製品、グルコースモニタリング製品、心代謝モニタリング製品、感染症検査製品)、プラットフォーム別(Lateral Flow Assays、Dipsticks、マイクロ流体分子診断、免疫測定)、購入形態別(OTC製品、処方箋ベースの製品)、エンドユーザー別(臨床検査室、病院。外来診療施設および医師事務所、薬局、小売クリニック、Eコマースプラットフォーム、病院、クリティカルケアセンター、緊急医療センター、ホームケアおよび自己検査、その他のエンドユーザー)および地域別予測 2022-2028Global Point of Care & Rapid Diagnostics Market Size study, by Product (COVID-19 test products, Glucose Monitoring Products, Cardiometabolic Monitoring Products, Infectious Disease Testing Products), By platform (Lateral Flow Assays, Dipsticks, Microfluidics Molecular Diagnostics, Immunoassays), by Mode of Purchase (OTC Products, Prescription-based Products), by End-User (Clinical Laboratories. Ambulatory Care Facilities and Physician Offices, Pharmacies, retail clinics, & E-commerce Platforms, Hospitals, Critical Care Centers, Urgent care centers, Home Care & Self Testing, Other End-Users) and Regional Forecasts 2022-2028 ポイントケア&迅速診断の世界市場は、2021年に約388億9000万米ドルと評価され、予測期間2022-2028年には10.80%以上の健全な成長率で成長すると予測されています。心臓病、がん、糖尿病など、さまざまな病気の調... もっと見る
サマリーポイントケア&迅速診断の世界市場は、2021年に約388億9000万米ドルと評価され、予測期間2022-2028年には10.80%以上の健全な成長率で成長すると予測されています。心臓病、がん、糖尿病など、さまざまな病気の調査ですぐに結果を得るために利用されるポイントオブケアおよび迅速診断薬は、ポイントオブケア(POC)および迅速診断薬市場として定義されています。この市場は、政府の支援政策や感染症の高い流行といった主要な要因によって牽引されています。心臓病、肝炎、がん、消化器、呼吸器、性感染症(STD)などの慢性疾患や感染症の有病率の上昇が、世界のポイントオブケア・迅速診断市場を牽引しています。例えば、UNAIDSによると、2018年には東・南アフリカの2060万人がHIVと共存しています。中東・北アフリカでは、2019年に2万人のHIV新規感染が報告されました。さらに、2019年には、アジア太平洋地域で推定580万人がHIVに感染しており、インドと中国がその先頭を走っています。インドでは、2019年に210万人以上がHIVに感染しています。したがって、HIVの高い感染率は、ポイントオブケア診断薬および迅速診断薬の需要の増加をもたらしています。また、製品開発のための投資や資金調達の増加、新規技術に関するプロバイダーの意識の高まりは、今後数年間、有利な機会を生み出します。しかし、厳しい規制政策が、2022-2028年の予測期間における市場の成長を阻害しています。Point of Care & Rapid Diagnosticsの世界市場分析で考慮した地域は、アジア太平洋、北米、欧州、中南米、その他の地域です。北米が市場の成長をリードし、欧州がそれに続いています。成長を支える要因としては、製品承認数の増加や生活習慣病の有病率の上昇が挙げられます。しかし、医療費の増加や疾病の早期発見に対する意識の高まりから、ラテンアメリカが最も急速に成長すると予測されています。 本レポートに含まれる主な市場プレイヤーは以下の通りです: アボット・ラボラトリーズ シーメンス・ヘルスィーナーズAG クィデル株式会社 F.ホフマン・ラ・ロシュ社 ダナハーコーポレーション ベクトン・ディッキンソン・アンド・カンパニー チェンビオ・ダイアグノスティックス EKFダイアグノスティックス トリニティ・バイオテック・ピーエルシー 計測機器研究所 本調査の目的は、近年における様々なセグメント&国の市場規模を定義し、今後8年間の値を予測することです。本レポートは、本調査の対象である各地域・国において、産業の質的・量的な側面を取り込むよう設計されています。さらに、市場の将来的な成長を規定する推進要因や課題など、重要な側面に関する詳細な情報も提供しています。さらに、本レポートでは、主要企業の競争環境と製品提供の詳細な分析とともに、関係者が投資するためのミクロ市場での利用可能な機会も組み込んでいます。市場の詳細なセグメントとサブセグメントを以下に説明する: 製品別 COVID-19テスト製品 グルコースモニタリング製品 カーディオメタボリックモニタリング製品 感染症検査製品 プラットフォーム別 ラテラルフローアッセイ ディップスティック マイクロフルイディクス 分子生物学的診断法 イムノアッセイ 購入形態別: 処方箋に基づく製品 OTC製品 エンドユーザー 臨床検査室 外来診療施設および医師事務所 薬局、小売クリニック、Eコマースプラットフォーム 病院、クリティカルケアセンター、アージェントケアセンター ホームケア&セルフテスト その他のエンドユーザー 地域別 北アメリカ U.S. カナダ ヨーロッパ 連邦王国 ドイツ フランス スペイン イタリア ROE アジア太平洋 中国 インド 日本 オーストラリア 南朝鮮 ロアパック ラテンアメリカ ブラジル メキシコ その他の地域 さらに、本調査で考慮した年は以下の通りです: 歴史的年号-2018年、2019年、2020年 基準年 - 2021年 予測期間 - 2022年~2028年 市場調査におけるPoint of Care & Rapid Diagnosticsの世界市場のターゲットオーディエンス: 主なコンサルティング会社・アドバイザーのご紹介 大企業・中堅企業・中小企業 ベンチャーキャピタル 付加価値再販業者(VAR) サードパーティナレッジプロバイダー 投資銀行家 投資家の皆様へ 目次Chapter 1. Executive Summary1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion) 1.2.1. Global Point of Care & Rapid Diagnostics Market, by Region, 2020-2028 (USD Billion) 1.2.2. Global Point of Care & Rapid Diagnostics Market, by Product type, 2020-2028 (USD Billion) 1.2.3. Global Point of Care & Rapid Diagnostics Market, by Platform, 2020-2028 (USD Billion) 1.2.4. Global Point of Care & Rapid Diagnostics Market, by Mode of Purchase, 2020-2028 (USD Billion) 1.2.5. Global Point of Care & Rapid Diagnostics Market, by End-User, 2020-2028 (USD Billion) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Point of Care & Rapid Diagnostics Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Point of Care & Rapid Diagnostics Market Dynamics 3.1. Point of Care & Rapid Diagnostics Market Impact Analysis (2020-2028) 3.1.1. Market Drivers 3.1.1.1. Supportive government policies 3.1.1.2. High prevalence of infectious diseases 3.1.2. Market Challenges 3.1.2.1. Stringent regulatory policies 3.1.2.2. Pricing pressure owing to reimbursement cuts and budget constraints 3.1.3. Market Opportunities 3.1.3.1. Growing investments and funding for product development 3.1.3.2. Increasing provider awareness about novel technologies Chapter 4. Global Point of Care & Rapid Diagnostics Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion 4.5. Top investment opportunity 4.6. Top winning strategies Chapter 5. Risk Assessment: COVID-19 Impact 5.1.1. Assessment of the overall impact of COVID-19 on the industry 5.1.2. Pre COVID-19 and post COVID-19 Market scenario Chapter 6. Global Point of Care & Rapid Diagnostics Market, by Product Type 6.1. Market Snapshot 6.2. Global Point of Care & Rapid Diagnostics Market by Product Type, Performance - Potential Analysis 6.3. Global Point of Care & Rapid Diagnostics Market Estimates & Forecasts by Product Type, 2019-2028 (USD Billion) 6.4. Point of Care & Rapid Diagnostics Market, Sub Segment Analysis 6.4.1. COVID-19 test products 6.4.2. Glucose Monitoring Products 6.4.3. Cardiometabolic Monitoring Products 6.4.4. Infectious Disease Testing Products Chapter 7. Global Point of Care & Rapid Diagnostics Market, by Platform 7.1. Market Snapshot 7.2. Global Point of Care & Rapid Diagnostics Market by Platform, Performance - Potential Analysis 7.3. Global Point of Care & Rapid Diagnostics Market Estimates & Forecasts by Platform, 2019-2028 (USD Billion) 7.4. Point of Care & Rapid Diagnostics Market, Sub Segment Analysis 7.4.1. Lateral Flow Assays 7.4.2. Dipsticks 7.4.3. Microfluidics 7.4.4. Molecular Diagnostics 7.4.5. Immunoassays Chapter 8. Global Point of Care & Rapid Diagnostics Market, by Mode of Purchase 8.1. Market Snapshot 8.2. Global Point of Care & Rapid Diagnostics Market by Mode of Purchase, Performance - Potential Analysis 8.3. Global Point of Care & Rapid Diagnostics Market Estimates & Forecasts by Mode of Purchase, 2019-2028 (USD Billion) 8.4. Point of Care & Rapid Diagnostics Market, Sub Segment Analysis 8.4.1. Prescription-based Products 8.4.2. OTC Products Chapter 9. Global Point of Care & Rapid Diagnostics Market, by End-User 9.1. Market Snapshot 9.2. Global Point of Care & Rapid Diagnostics Market by End-User, Performance - Potential Analysis 9.3. Global Point of Care & Rapid Diagnostics Market Estimates & Forecasts by End-User, 2019-2028 (USD Billion) 9.4. Point of Care & Rapid Diagnostics Market, Sub Segment Analysis 9.4.1. Clinical Laboratories 9.4.2. Ambulatory Care Facilities and Physician Offices 9.4.3. Pharmacies, retail clinics, & E-commerce Platforms 9.4.4. Hospitals, Critical Care Centers, Urgent care centers 9.4.5. Home Care & Self Testing 9.4.6. Other End-Users Chapter 10. Global Point of Care & Rapid Diagnostics Market, Regional Analysis 10.1. Point of Care & Rapid Diagnostics Market, Regional Market Snapshot 10.2. North America Point of Care & Rapid Diagnostics Market 10.2.1. U.S. Point of Care & Rapid Diagnostics Market 10.2.1.1. Product Type breakdown estimates & forecasts, 2019-2028 10.2.1.2. Platform breakdown estimates & forecasts, 2019-2028 10.2.1.3. Mode of Purchase breakdown estimates & forecasts, 2019-2028 10.2.1.4. End-User breakdown estimates & forecasts, 2019-2028 10.2.2. Canada Point of Care & Rapid Diagnostics Market 10.3. Europe Point of Care & Rapid Diagnostics Market Snapshot 10.3.1. U.K. Point of Care & Rapid Diagnostics Market 10.3.2. Germany Point of Care & Rapid Diagnostics Market 10.3.3. France Point of Care & Rapid Diagnostics Market 10.3.4. Spain Point of Care & Rapid Diagnostics Market 10.3.5. Italy Point of Care & Rapid Diagnostics Market 10.3.6. Rest of Europe Point of Care & Rapid Diagnostics Market 10.4. Asia-Pacific Point of Care & Rapid Diagnostics Market Snapshot 10.4.1. China Point of Care & Rapid Diagnostics Market 10.4.2. India Point of Care & Rapid Diagnostics Market 10.4.3. Japan Point of Care & Rapid Diagnostics Market 10.4.4. Australia Point of Care & Rapid Diagnostics Market 10.4.5. South Korea Point of Care & Rapid Diagnostics Market 10.4.6. Rest of Asia Pacific Point of Care & Rapid Diagnostics Market 10.5. Latin America Point of Care & Rapid Diagnostics Market Snapshot 10.5.1. Brazil Point of Care & Rapid Diagnostics Market 10.5.2. Mexico Point of Care & Rapid Diagnostics Market 10.6. Rest of The World Point of Care & Rapid Diagnostics Market Chapter 11. Competitive Intelligence 11.1. Top Market Strategies 11.2. Company Profiles 11.2.1. Becton, Dickinson and Company 11.2.1.1. Key Information 11.2.1.2. Overview 11.2.1.3. Financial (Subject to Data Availability) 11.2.1.4. Product Summary 11.2.1.5. Recent Developments 11.2.2. Abbott Laboratories 11.2.3. F. Hoffman-La Roche Ltd. 11.2.4. Danaher Corporation 11.2.5. Instrumentation Laboratory 11.2.6. Quidel Corporation 11.2.7. Siemens Healthineers AG 11.2.8. Chembio Diagnostics 11.2.9. Trinity Biotech plc 11.2.10. EKF Diagnostics Chapter 12. Research Process 12.1. Research Process 12.1.1. Data Mining 12.1.2. Analysis 12.1.3. Market Estimation 12.1.4. Validation 12.1.5. Publishing 12.2. Research Attributes 12.3. Research Assumption
SummaryGlobal Point of care & Rapid Diagnostics Market is valued at approximately USD 38.89 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.80% over the forecast period 2022-2028. The point of care and rapid diagnostics utilized to get an immediate result in the investigation of various diseases such as heart diseases, cancer, diabetes, and others are defined as a point of care (POC) and rapid diagnostics market. The market is driven by key factors such as supportive government policies and high prevalence of infectious diseases. The rising prevalence of chronic and infectious illnesses such as heart disease, hepatitis, cancer, gastrointestinal, respiratory, and sexually transmitted diseases (STDs) is driving the global point of care and rapid diagnostics market. For instance, According to UNAIDS, 20.6 million persons in East and Southern Africa were living with HIV in 2018. In the Middle East and North Africa, 20,000 new HIV infections were reported in 2019. Moreover, in 2019, an estimated 5.8 million persons in Asia Pacific were infected with HIV, with India and China leading the way. In India, over 2.1 million persons were infected with HIV in 2019. Hence, high incidence of HIV has led to an increase in demand for point-of-care and rapid diagnostics. Also, growing investments and funding for product development and increasing provider awareness about novel technologies create lucrative opportunities in the upcoming years. However, stringent regulatory policies impede the growth of the market over the forecast period of 2022-2028. Table of ContentsChapter 1. Executive Summary1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion) 1.2.1. Global Point of Care & Rapid Diagnostics Market, by Region, 2020-2028 (USD Billion) 1.2.2. Global Point of Care & Rapid Diagnostics Market, by Product type, 2020-2028 (USD Billion) 1.2.3. Global Point of Care & Rapid Diagnostics Market, by Platform, 2020-2028 (USD Billion) 1.2.4. Global Point of Care & Rapid Diagnostics Market, by Mode of Purchase, 2020-2028 (USD Billion) 1.2.5. Global Point of Care & Rapid Diagnostics Market, by End-User, 2020-2028 (USD Billion) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Point of Care & Rapid Diagnostics Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Point of Care & Rapid Diagnostics Market Dynamics 3.1. Point of Care & Rapid Diagnostics Market Impact Analysis (2020-2028) 3.1.1. Market Drivers 3.1.1.1. Supportive government policies 3.1.1.2. High prevalence of infectious diseases 3.1.2. Market Challenges 3.1.2.1. Stringent regulatory policies 3.1.2.2. Pricing pressure owing to reimbursement cuts and budget constraints 3.1.3. Market Opportunities 3.1.3.1. Growing investments and funding for product development 3.1.3.2. Increasing provider awareness about novel technologies Chapter 4. Global Point of Care & Rapid Diagnostics Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion 4.5. Top investment opportunity 4.6. Top winning strategies Chapter 5. Risk Assessment: COVID-19 Impact 5.1.1. Assessment of the overall impact of COVID-19 on the industry 5.1.2. Pre COVID-19 and post COVID-19 Market scenario Chapter 6. Global Point of Care & Rapid Diagnostics Market, by Product Type 6.1. Market Snapshot 6.2. Global Point of Care & Rapid Diagnostics Market by Product Type, Performance - Potential Analysis 6.3. Global Point of Care & Rapid Diagnostics Market Estimates & Forecasts by Product Type, 2019-2028 (USD Billion) 6.4. Point of Care & Rapid Diagnostics Market, Sub Segment Analysis 6.4.1. COVID-19 test products 6.4.2. Glucose Monitoring Products 6.4.3. Cardiometabolic Monitoring Products 6.4.4. Infectious Disease Testing Products Chapter 7. Global Point of Care & Rapid Diagnostics Market, by Platform 7.1. Market Snapshot 7.2. Global Point of Care & Rapid Diagnostics Market by Platform, Performance - Potential Analysis 7.3. Global Point of Care & Rapid Diagnostics Market Estimates & Forecasts by Platform, 2019-2028 (USD Billion) 7.4. Point of Care & Rapid Diagnostics Market, Sub Segment Analysis 7.4.1. Lateral Flow Assays 7.4.2. Dipsticks 7.4.3. Microfluidics 7.4.4. Molecular Diagnostics 7.4.5. Immunoassays Chapter 8. Global Point of Care & Rapid Diagnostics Market, by Mode of Purchase 8.1. Market Snapshot 8.2. Global Point of Care & Rapid Diagnostics Market by Mode of Purchase, Performance - Potential Analysis 8.3. Global Point of Care & Rapid Diagnostics Market Estimates & Forecasts by Mode of Purchase, 2019-2028 (USD Billion) 8.4. Point of Care & Rapid Diagnostics Market, Sub Segment Analysis 8.4.1. Prescription-based Products 8.4.2. OTC Products Chapter 9. Global Point of Care & Rapid Diagnostics Market, by End-User 9.1. Market Snapshot 9.2. Global Point of Care & Rapid Diagnostics Market by End-User, Performance - Potential Analysis 9.3. Global Point of Care & Rapid Diagnostics Market Estimates & Forecasts by End-User, 2019-2028 (USD Billion) 9.4. Point of Care & Rapid Diagnostics Market, Sub Segment Analysis 9.4.1. Clinical Laboratories 9.4.2. Ambulatory Care Facilities and Physician Offices 9.4.3. Pharmacies, retail clinics, & E-commerce Platforms 9.4.4. Hospitals, Critical Care Centers, Urgent care centers 9.4.5. Home Care & Self Testing 9.4.6. Other End-Users Chapter 10. Global Point of Care & Rapid Diagnostics Market, Regional Analysis 10.1. Point of Care & Rapid Diagnostics Market, Regional Market Snapshot 10.2. North America Point of Care & Rapid Diagnostics Market 10.2.1. U.S. Point of Care & Rapid Diagnostics Market 10.2.1.1. Product Type breakdown estimates & forecasts, 2019-2028 10.2.1.2. Platform breakdown estimates & forecasts, 2019-2028 10.2.1.3. Mode of Purchase breakdown estimates & forecasts, 2019-2028 10.2.1.4. End-User breakdown estimates & forecasts, 2019-2028 10.2.2. Canada Point of Care & Rapid Diagnostics Market 10.3. Europe Point of Care & Rapid Diagnostics Market Snapshot 10.3.1. U.K. Point of Care & Rapid Diagnostics Market 10.3.2. Germany Point of Care & Rapid Diagnostics Market 10.3.3. France Point of Care & Rapid Diagnostics Market 10.3.4. Spain Point of Care & Rapid Diagnostics Market 10.3.5. Italy Point of Care & Rapid Diagnostics Market 10.3.6. Rest of Europe Point of Care & Rapid Diagnostics Market 10.4. Asia-Pacific Point of Care & Rapid Diagnostics Market Snapshot 10.4.1. China Point of Care & Rapid Diagnostics Market 10.4.2. India Point of Care & Rapid Diagnostics Market 10.4.3. Japan Point of Care & Rapid Diagnostics Market 10.4.4. Australia Point of Care & Rapid Diagnostics Market 10.4.5. South Korea Point of Care & Rapid Diagnostics Market 10.4.6. Rest of Asia Pacific Point of Care & Rapid Diagnostics Market 10.5. Latin America Point of Care & Rapid Diagnostics Market Snapshot 10.5.1. Brazil Point of Care & Rapid Diagnostics Market 10.5.2. Mexico Point of Care & Rapid Diagnostics Market 10.6. Rest of The World Point of Care & Rapid Diagnostics Market Chapter 11. Competitive Intelligence 11.1. Top Market Strategies 11.2. Company Profiles 11.2.1. Becton, Dickinson and Company 11.2.1.1. Key Information 11.2.1.2. Overview 11.2.1.3. Financial (Subject to Data Availability) 11.2.1.4. Product Summary 11.2.1.5. Recent Developments 11.2.2. Abbott Laboratories 11.2.3. F. Hoffman-La Roche Ltd. 11.2.4. Danaher Corporation 11.2.5. Instrumentation Laboratory 11.2.6. Quidel Corporation 11.2.7. Siemens Healthineers AG 11.2.8. Chembio Diagnostics 11.2.9. Trinity Biotech plc 11.2.10. EKF Diagnostics Chapter 12. Research Process 12.1. Research Process 12.1.1. Data Mining 12.1.2. Analysis 12.1.3. Market Estimation 12.1.4. Validation 12.1.5. Publishing 12.2. Research Attributes 12.3. Research Assumption
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポート
Bizwit Research & Consulting LLP社の医療デバイス・機器分野での最新刊レポート
本レポートと同じKEY WORD(ambulatory care)の最新刊レポート
よくあるご質問Bizwit Research & Consulting LLP社はどのような調査会社ですか?Bizwit Research & Consulting (Bizwit Research & Consulting LLP)は世界の多様なマクロおよびマイクロ経済の動向を継続的に調査しています。 ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |